Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease

ClinicalTrials.gov ID: NCT00162032

Public ClinicalTrials.gov record NCT00162032. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 6:36 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Open-Label, Non-Randomized, International, Multicenter Trial to Evaluate the Efficacy and Safety of CARDIOLITE® Myocardial Perfusion Imaging in Pediatric Subjects With Kawasaki Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Determine the predictive value of CARDIOLITE® rest and stress myocardial perfusion imaging (MPI) to define a pediatric population with Kawasaki Disease (KD) at high and low risk of developing cardiac events.

Study identification

NCT ID
NCT00162032
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Lantheus Medical Imaging
Industry
Enrollment
445 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
4 Years to 16 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2005 (Type not available)
Primary completion
May 2010 (Actual)
Completion
Dec 2010 (Actual)
Last update posted
Jul 23, 2019

2005 – 2010

United States locations

U.S. sites
29
U.S. states
18
U.S. cities
28
Facility City State ZIP Site status
Local Institution Anchorage Alaska 99508 —
Local Institution Little Rock Arkansas 72202 —
Local Institution Los Angeles California 90027 —
Local Institution Orange California 92868 —
Local Institution San Diego California 92123 —
Local Institution Denver Colorado 80218 —
Local Institution Hartford Connecticut 06106 —
Local Institution New Haven Connecticut 06511 —
Local Institution Honolulu Hawaii 96813 —
Local Institution Chicago Illinois 60614 —
Local Institution Chicago Illinois 60637 —
Local Institution Park Ridge Illinois 60068 —
Local Institution Indianapolis Indiana 46201 —
Local Institution Lexington Kentucky 40536 —
Local Institution Boston Massachusetts 02111 —
Local Institution Las Vegas Nevada 89109 —
Local Institution New Hyde Park New York 11040 —
Local Institution New York New York 10032 —
Local Institution Durham North Carolina 27710 —
Local Institution Greenville North Carolina 27858 —
Local Institution Cincinnati Ohio 45229 —
Local Institution Cleveland Ohio 44101 —
Local Institution Hershey Pennsylvania 17033 —
Local Institution Philadelphia Pennsylvania 19107 —
Local Institution Pittsburgh Pennsylvania 15213 —
Local Institution Charlottesville Virginia 22906 —
Local Institution Seattle Washington 98105 —
Local Institution Spokane Washington 99204 —
Local Institution Milwaukee Wisconsin 53203 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00162032, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 23, 2019 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00162032 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →